Actively Recruiting
Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia
Led by Beni-Suef University · Updated on 2025-01-07
140
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to fill the knowledge gap by investigating the predictors of success for TPVB in patients with herpetic neuralgia. By identifying demographic, clinical, previous medications and procedural factors associated with positive outcomes, this research seeks to enhance the efficacy of TPVB and improve pain management strategies for patients suffering from herpetic neuralgia.
CONDITIONS
Official Title
Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged from18 to 70 years
- Diagnosed with herpetic neuralgia
- Able and willing to provide informed consent
- ASA physical status I - II
- Pain affecting one dermatomal area
- Pain located in the thoracic region
You will not qualify if you...
- Infection at site of injection, empyema, coagulopathy, or neoplastic lesion in paravertebral space
- Known allergies to bupivacaine or dexamethasone
- Severe health conditions that could affect study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beni Suef University Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt, 62814
Actively Recruiting
Research Team
D
Dina M Fakhry, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here